Breast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells

Immunology and Microbiology

• Cancer Cell 100%
• Carcinoma Cell 100%
• Cell Proliferation 66%
• Cell Line 66%
• Normal Human 66%
• Genetic Screening 33%
• Tumor Cell 33%
• Mediator 33%
• Cell Growth 33%
• Immunoprecipitation 33%
• Placenta 33%
• Growth Inhibition 33%
• Western Blot 33%
• Gene Inactivation 33%
• Growth Stimulation 33%
• Reverse Transcription Polymerase Chain Reaction 33%
• In Vitro 33%

Keyphrases

• Breast Cancer 100%
• Lobular Carcinoma 100%
• Antiestrogen Resistance 100%
• Carcinoma Cells 100%
• ERBB2 21%
• MRNA Expression 15%
• Breast Cancer Cells 15%
• Knockdown 10%
• Cell Proliferation 10%
• Primary Breast Cancer 10%
• Lapatinib 10%
• MDA-MB-453 10%
• Expression Level 5%
• Genetic Screening 5%
• Small Interfering RNA (siRNA) 5%
• Quantitative PCR 5%
• Multifunctional Protein 5%
• Gene Silencing 5%
• Downstream Targets 5%
• Tumor Cell Proliferation 5%
• Placenta 5%
• Breast Cells 5%
• Growth Suppression 5%
• Human Breast Cancer 5%
• Western Blot Assay 5%
• Identified Genes 5%
• Tamoxifen Resistance 5%
• Immunoprecipitation Assay 5%
• Estrogenic 5%
• Level of Functioning 5%
• Proliferation Resistance 5%
• Lobular Breast Cancer 5%
• Endocrine-resistant Breast Cancer 5%
• Endocrine Resistance 5%
• Antiestrogen 5%
• Growth Stimulation 5%
• Functional Genetics 5%
• ZR-75-1 5%
• New Antibodies 5%
• In Vitro Cell Model 5%